Latest Diabetes News
Semaglutide helps patients with diabetes reduce blood glucose levels and lower body weight.
Lifestyle and clinical factors could have been misinterpreted, linking antibiotics to risk of diabetes.
Sulfonylureas and thiazolidinediones adherence was stronger than metformin adherence.
Diabetic patients with chronic kidney disease starting treatment with metformin have a 36% decreased risk of death compared with those starting on a sulfonylurea, study finds.
Severe hypoglycemia is associated with coronary heart disease, cardiovascular mortality, and cancer mortality.
Chemicals that inhibit endocrine functions may be associated with contrasts in diabetes-linked racial and socioeconomic disparities.
The combined effects of high BMI and diabetes resulted in 5.6% of all incident cancers in 2012.
For patients with diabetes, there was a significant decrease in hospitalization rates for acute coronary syndrome, cardiac dysrhythmia, heart failure, and certain strokes.
Effect is larger in chronic heart failure patients with diabetes than CHF patients without diabetes.
But sulfonylureas still most common drugs initiated as second-line treatment.
But significant improvements in HbA1c testing and awareness seen, except in those aged 20 to 44.
Increased risk seen for both all-cause mortality, sudden cardiac death in young people with diabetes.
Findings among a large study of Norwegian children followed for 40-plus years.
From 1995 to 2015, the prevalence of hypertension and diabetes among patients starting hemodialysis increased from 67.9% to 87.6% and from 43.1% to 59.6%, respectively.
In any Diabetes Prevention Program treatment group, statin use tied to increased diabetes risk.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)